BIOKNOSTIC
- Biotech or pharma, therapeutic R&D
At BK, we are redefining vaccination with Nanoparticulated Vaccinex, our proprietary nanovaccine platform enhanced by powerful super-adjuvants. This next-generation technology enables precise delivery and immune activation, even for non-immunogenic antigens. Integrated into nanoscale carriers, our adjuvants amplify innate and adaptive responses while reducing required doses and side effects. The result: more effective, longer-lasting, and safer vaccines. Thermostable and modular, Nanoparticulated Vaccinex is built for infectious diseases, oncology, and future pandemics. We are partnering globally to bring this breakthrough to patients.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}